Author

Daniel W. Sherbenou

University of Colorado AnschutzORCID 0000-0003-3013-7174Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Denis J. OhlstromiD· 3 shared Ajay K. NookaiD· 2 shared Alessandro LaganàiD· 2 shared Junia Vieira Dos SantosiD· 2 shared Katherine E. FergusoniD· 2 shared Manoj BhasiniD· 2 shared Marina E. MichaudiD· 2 shared Sagar LonialiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Denis J. OhlstromORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 25, 2026

Spatial multi-omics of multiple myeloma uncovers niche-dependent pro-myeloma and immunosuppressive signaling in the bone marrow and extramedullary lesions

Denis J. Ohlstrom, Marina E. Michaud, Mojtaba Bakhtiari…·Manoj Bhasin

This study uses spatial and single-cell transcriptomics to identify niche-specific signaling programs in multiple myeloma that drive progression and immunosuppression.

1 citation

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 27, 2025

Longitudinal multi-omic profiling uncovers immune escape and predictors of response in multiple myeloma

Denis J. Ohlstrom, William Pilcher, Marina E. Michaud…·Manoj Bhasin

This study uses longitudinal multi-omic profiling to identify immune escape mechanisms and predictors of response in multiple myeloma.

2 citations

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyMolecular Cancer ResearchPeer-reviewedMar 6, 2025

Ribosome Profiling Reveals Translational Reprogramming via mTOR Activation in Omacetaxine Resistant Multiple Myeloma

Zachary J. Walker, Katherine F. Vaeth, Amber Baldwin…·Daniel W. Sherbenou

This study identifies translational reprogramming via mTOR activation as a mechanism of omacetaxine resistance in multiple myeloma and suggests combination therapy with mTOR inhibitors.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky